These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4992805)

  • 1. [The specificity of anthrax toxin obtained in vitro].
    Fedotova IuM; Ulanova AA
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Mar; 47(3):111-3. PubMed ID: 4992805
    [No Abstract]   [Full Text] [Related]  

  • 2. STUDIES ON ANTHRAX INFECTIONS IN IMMUNIZED GUINEA PIGS.
    WARD MK; MCGANN VG; HOGGE AL; HUFF ML; KANODE RG; ROBERTS EO
    J Infect Dis; 1965 Feb; 115():59-67. PubMed ID: 14258478
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapid lethal effect in rats of a third component found upon fractionating the toxin of Bacillus anthracis.
    BEALL FA; TAYLOR MJ; THORNE CB
    J Bacteriol; 1962 Jun; 83(6):1274-80. PubMed ID: 13866126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [FURTHER DATA ON THE PATHOGENESIS OF ANTHRAX INFECTION AND ANTI-ANTHRAX IMMUNITY].
    STAMATIN N
    Microbiol Parazitol Epidemiol (Bucur); 1964; 9():477-91. PubMed ID: 14312709
    [No Abstract]   [Full Text] [Related]  

  • 5. The three factors of anthrax toxin: their immunogenicity and lack of demonstrable enzymic activity.
    STANLEY JL; SMITH H
    J Gen Microbiol; 1963 May; 31():329-37. PubMed ID: 13983400
    [No Abstract]   [Full Text] [Related]  

  • 6. THE CHEMICAL BASIS OF THE VIRULENCE OF BACILLUS ANTHRACIS. IX. ITS AGGRESSINS AND THEIR MODE OF ACTION.
    KEPPIE J; HARRIS-SMITH PW; SMITH H
    Br J Exp Pathol; 1963 Aug; 44(4):446-53. PubMed ID: 14079018
    [No Abstract]   [Full Text] [Related]  

  • 7. Purification of factor I and recognition of a third factor of the anthrax toxin.
    STANLEY JL; SMITH H
    J Gen Microbiol; 1961 Sep; 26():49-63. PubMed ID: 13916257
    [No Abstract]   [Full Text] [Related]  

  • 8. [Extraction of the exotoxin of anthrax vaccinal strain STI-1].
    Lesniak OT; Saltykov RA
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Feb; (2):110-3. PubMed ID: 4218021
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunologic studies of anthrax. IV. Evaluation of the immunogenicity of three components of anthrax toxin.
    Mahlandt BG; Klein F; Lincoln RE; Haines BW; Jones WI; Friedman RH
    J Immunol; 1966 Apr; 96(4):727-33. PubMed ID: 4956875
    [No Abstract]   [Full Text] [Related]  

  • 10. Toxin production as a criterion for differentiating Bacillus cereus and Bacillus anthracis.
    BONVENTRE PF; ECKERT NJ
    J Bacteriol; 1963 Feb; 85(2):490-1. PubMed ID: 14013788
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunological properties of the preparations of the anti-anthrax antigen].
    Shliakhov EN; Gruz EV; Burdenko TA; Moroz LV
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Sep; (9):41-5. PubMed ID: 413294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of toxin in vitro by Bacillus anthracis and its spearation into two components.
    THORNE CB; MOLNAR DM; STRANGE RE
    J Bacteriol; 1960 Mar; 79(3):450-5. PubMed ID: 13838209
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of anthrax toxin on cells in cultures in vitro].
    Fedotova IuM
    Arkh Patol; 1970; 32(11):30-3. PubMed ID: 4993241
    [No Abstract]   [Full Text] [Related]  

  • 14. ALTERATIONS IN THE BIOLOGICAL ACTIVITY OF PROTECTIVE ANTIGEN OF BACILLUS ANTHRACIS TOXIN.
    MOLNAR DM; ALTENBERN RA
    Proc Soc Exp Biol Med; 1963 Nov; 114():294-7. PubMed ID: 14101169
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects "in vitro" of anthrax exudate on the speed of translation of human histiocytes. Micrometric studies in phase contrast].
    Lanzarini GF; Santagati G; Carcò FP
    Ig Mod; 1965; 58(11):1044-52. PubMed ID: 4965235
    [No Abstract]   [Full Text] [Related]  

  • 16. Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax.
    Albrecht MT; Li H; Williamson ED; LeButt CS; Flick-Smith HC; Quinn CP; Westra H; Galloway D; Mateczun A; Goldman S; Groen H; Baillie LW
    Infect Immun; 2007 Nov; 75(11):5425-33. PubMed ID: 17646360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of field data for extrapolation in anthrax.
    Lincoln RE; Walker JS; Klein F; Rosenwald AJ; Jones WI
    Fed Proc; 1967 Sep; 26(5):1558-62. PubMed ID: 4963771
    [No Abstract]   [Full Text] [Related]  

  • 18. INDUCIBLE LYTIC SYSTEMS IN THE GENUS BACILLUS.
    ALTENBERN RA; STULL HB
    J Gen Microbiol; 1965 Apr; 39():53-62. PubMed ID: 14328413
    [No Abstract]   [Full Text] [Related]  

  • 19. Growth characteristics of Bacillus anthracis compared to other Bacillus spp. on the selective nutrient media Anthrax Blood Agar and Cereus Ident Agar.
    Tomaso H; Bartling C; Al Dahouk S; Hagen RM; Scholz HC; Beyer W; Neubauer H
    Syst Appl Microbiol; 2006 Jan; 29(1):24-8. PubMed ID: 16423652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.
    Bielinska AU; Janczak KW; Landers JJ; Makidon P; Sower LE; Peterson JW; Baker JR
    Infect Immun; 2007 Aug; 75(8):4020-9. PubMed ID: 17502384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.